CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2021-05-29 张晓梅-Xiaomei Zhang

期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。
大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏

194 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2020-07-28 silent111

审稿速度:1.0 | 投稿命中率:25.0
经验分享：Stage
Start Date
Decision Pending
2020-07-27 12:32:30
Under Review
2020-07-27 12:32:23
Under Editorial Consideration
2020-07-27 00:14:55
Initial QC
2020-07-23 09:04:59
Manuscript Submission
2020-07-18 06:59:50
这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267

241 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2021-12-01 ms4000001412745107

under reviewer 一天变成 decision pending 估计悲剧了 😭

72 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2020-07-17 Dr. X.

审稿速度:1.0 | 投稿命中率:50.0
经验分享：文章刚刚接收，贴个timeline，供大家参考：
第一稿
Stage Start Date
Revision Received 2020-04-09 14:44:05
Waiting for Revision 2020-04-09 14:39:37
Decision Sent to Author 2020-04-09 14:39:37
Decision Pending 2020-04-06 17:45:32
Under Review 2020-03-07 11:36:22
Under Editorial Consideration 2020-03-06 13:06:37
Initial QC 2020-03-05 16:58:41
Manuscript Submission 2020-03-04 16:35:38
第二稿：疫情期间，补了实验
Stage Start Date
Revision Received 2020-07-11 06:25:26
Waiting for Revision 2020-07-09 08:38:16
Decision Sent to Author 2020-07-09 08:38:16
Decision Pending 2020-06-29 08:28:42
Under Review 2020-06-25 09:38:03
Under Editorial Consideration 2020-06-23 10:09:56
Manuscript Submission 2020-04-09 14:44:05
第三稿：原则上已经接收，改了一下要求的格式
Stage Start Date
Manuscript Ready for Publication 2020-07-16 10:45:24
Decision Sent to Author 2020-07-16 10:45:24
Decision Pending 2020-07-16 10:44:15
Under Review 2020-07-16 10:44:14
Under Editorial Consideration 2020-07-12 05:16:56
Manuscript Submission 2020-07-11 06:25:26

261 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2022-06-13 1663238685_12506575

CR内审和外审都是Under Review吗

112 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2024-03-11 147c9105m80(暂无昵称) 来自江苏省

under editorial consideration 已经六天了一点动静没有是什么情况呀

26 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2023-09-21 ms1000000959787142 来自天津

各位大佬们，这个杂志under editorial consideration 大概需要多久呀

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2022-10-16 ms2000001702708152

22.10.06投稿
22.10.10Under Review
22.1014收到外审邮件

183 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2022-11-09 124af5c7m81暂无昵称

请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？

82 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=969493, encodeId=7d30969493ae, content=期刊质量高，认可度很高。有一篇这个去申国自然青年基本稳中，面上也大概率能过函评。和其他8、9分的期刊像oncogene/cancer letter/Theranostics完全不是一个档次的。 大家还是争取发这种高质量期刊申基金才有用，现在内卷严重，评委不是吃素的，看到发的都是oncogene/cancer letter/Theranostics这种期刊基本没戏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Sat May 29 18:16:55 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804833, encodeId=4b7080483377, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Stage Start Date Decision Pending 2020-07-27 12:32:30 Under Review 2020-07-27 12:32:23 Under Editorial Consideration 2020-07-27 00:14:55 Initial QC 2020-07-23 09:04:59 Manuscript Submission 2020-07-18 06:59:50 这是我的文章状态，Dr.X你能给分析一下么？谢谢。我的Q是517861267, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47a61663560, createdName=silent111, createdTime=Tue Jul 28 06:52:18 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075970, encodeId=fa4d10e597036, content=under reviewer 一天变成 decision pending 估计悲剧了 😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Wed Dec 01 19:40:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803115, encodeId=5cd98031153d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：文章刚刚接收，贴个timeline，供大家参考： 第一稿 Stage Start Date Revision Received 2020-04-09 14:44:05 Waiting for Revision 2020-04-09 14:39:37 Decision Sent to Author 2020-04-09 14:39:37 Decision Pending 2020-04-06 17:45:32 Under Review 2020-03-07 11:36:22 Under Editorial Consideration 2020-03-06 13:06:37 Initial QC 2020-03-05 16:58:41 Manuscript Submission 2020-03-04 16:35:38 第二稿：疫情期间，补了实验 Stage Start Date Revision Received 2020-07-11 06:25:26 Waiting for Revision 2020-07-09 08:38:16 Decision Sent to Author 2020-07-09 08:38:16 Decision Pending 2020-06-29 08:28:42 Under Review 2020-06-25 09:38:03 Under Editorial Consideration 2020-06-23 10:09:56 Manuscript Submission 2020-04-09 14:44:05 第三稿：原则上已经接收，改了一下要求的格式 Stage Start Date Manuscript Ready for Publication 2020-07-16 10:45:24 Decision Sent to Author 2020-07-16 10:45:24 Decision Pending 2020-07-16 10:44:15 Under Review 2020-07-16 10:44:14 Under Editorial Consideration 2020-07-12 05:16:56 Manuscript Submission 2020-07-11 06:25:26 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5e55078563, createdName=Dr. X., createdTime=Fri Jul 17 16:20:42 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226137, encodeId=de88122613ec4, content=CR内审和外审都是Under Review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b48f5153036, createdName=1663238685_12506575, createdTime=Mon Jun 13 11:29:54 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094012, encodeId=ba082094012da, content=22.10.06投稿 22.10.10Under Review 22.1014收到外审邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f5f8299982, createdName=ms2000001702708152, createdTime=Sun Oct 16 10:33:47 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2023-05-30 ms3000001338909804 来自湖北省

偏重的研究方向：肿瘤基础研究;肿瘤
经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？

77 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务